• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Exagen Inc. - Common Stock (NQ:XGN)

    11.77 -0.15 (-1.26%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 210,508
    Open 11.94
    Bid (Size) 11.73 (2)
    Ask (Size) 11.78 (5)
    Prev. Close 11.92
    Today's Range 11.64 - 11.99
    52wk Range 2.380 - 11.99
    Shares Outstanding 16,126,784
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Beyond The Numbers: 4 Analysts Discuss Exagen Stock
     
    Via Benzinga
    Exagen Inc. to Participate in Third Quarter Investor Conferences
    From Exagen Inc.
    Via GlobeNewswire

    Performance

    YTD
    +280.9%
    +280.9%
    1 Month
    +29.2%
    +29.2%
    3 Month
    +63.9%
    +63.9%
    6 Month
    +162.1%
    +162.1%
    1 Year
    +318.9%
    +318.9%

    More News

    Read More
    What Analysts Are Saying About Exagen Stock
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Exagen Q2 Revenue Jumps 14 Percent
    Via The Motley Fool
    Topics Intellectual Property
    Earnings Scheduled For July 29, 2025
    Via Benzinga
    Earnings Scheduled For May 5, 2025
    Via Benzinga
    Exagen Inc (NASDAQ:XGN) Surpasses Revenue Estimates in Q2 2025 Despite Wider Loss, Shares Rally in Pre-Market Trading
    Via Chartmill
    Exagen Inc. Reports Strong Q2 2025 Results
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. Appoints Chas McKhann to Board of Directors
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
    From Exagen Inc.
    Via GlobeNewswire
    Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
    From Exagen Inc.
    Via GlobeNewswire
    Top movers in Thursday's pre-market session
    Via Chartmill
    Exagen Inc. Prices Public Offering of Common Stock
    From Exagen Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Get insights into the top gainers and losers of Wednesday's after-hours session.
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Exagen Inc. Announces Proposed Public Offering of Common Stock
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025
    From Exagen Inc.
    Via GlobeNewswire
    Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights
    From Exagen Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 11, 2025
    Via Benzinga
    Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
    From Exagen Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Exagen Inc. - Common Stock publicly traded?
    Yes, Exagen Inc. - Common Stock is publicly traded.
    What exchange does Exagen Inc. - Common Stock trade on?
    Exagen Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Exagen Inc. - Common Stock?
    The ticker symbol for Exagen Inc. - Common Stock is XGN on the Nasdaq Stock Market
    What is the current price of Exagen Inc. - Common Stock?
    The current price of Exagen Inc. - Common Stock is 11.77
    When was Exagen Inc. - Common Stock last traded?
    The last trade of Exagen Inc. - Common Stock was at 10/16/25 04:00 PM ET
    What is the market capitalization of Exagen Inc. - Common Stock?
    The market capitalization of Exagen Inc. - Common Stock is 189.81M
    How many shares of Exagen Inc. - Common Stock are outstanding?
    Exagen Inc. - Common Stock has 190M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.